netarsudil
Selected indexed studies
- Netarsudil. (, 2006) [PMID:30000985]
- Netarsudil-Induced Honeycomb Hypertrophy. (Asia Pac J Ophthalmol (Phila), 2023) [PMID:36650088]
- Topical Netarsudil in Childhood Glaucoma: A Systematic Review. (Curr Eye Res, 2025) [PMID:39749726]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Netarsudil. (2006) pubmed
- Netarsudil-Induced Honeycomb Hypertrophy. (2023) pubmed
- Topical Netarsudil in Childhood Glaucoma: A Systematic Review. (2025) pubmed
- PMID:39715311 (2024) pubmed
- MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension. (2024) pubmed
- Symptomatic Netarsudil-Induced Verticillata. (2023) pubmed
- Netarsudil-associated epithelial keratopathy. (2020) pubmed
- Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review. (2021) pubmed
- Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension. (2021) pubmed
- Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension. (2018) pubmed